RE/MAX (RMAX) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Annual meeting scheduled for May 14, 2025, with virtual participation available to shareholders.
Shareholders are encouraged to review proxy materials and vote by May 13, 2025.
Voting matters and shareholder proposals
Election of three directors: David Liniger, Annita Menogan, and Teresa Van De Bogart.
Advisory vote on executive compensation (say-on-pay) is on the agenda.
Proposal to amend the 2023 Omnibus Incentive Plan for approval.
Ratification of Ernst & Young LLP as independent auditor for fiscal year ending December 31, 2025.
Board of directors and corporate governance
Board recommends voting in favor of all proposals and director nominees.
Partial view of Summaries dataset, powered by Quartr API
Latest events from RE/MAX
- Q4 revenue and EBITDA declined, but global agent count hit a record and 2026 outlook is positive.RMAX
Q4 202520 Feb 2026 - Adjusted EBITDA rose 5.4% to $28.1M despite a 4.8% revenue decline in Q2 2024.RMAX
Q2 20241 Feb 2026 - Adjusted EBITDA rose 2% to $27.3M as cost controls and global agent growth offset U.S. declines.RMAX
Q3 202417 Jan 2026 - Modest U.S. housing growth, industry adaptation, and franchise-driven cash flow support future expansion.RMAX
Stephens 26th Annual Investment Conference | NASH202413 Jan 2026 - Adjusted EBITDA rose despite revenue decline, with international agent growth offsetting U.S. losses.RMAX
Q4 202424 Dec 2025 - Annual meeting to vote on directors, pay, equity plan, and auditor, with all proposals endorsed.RMAX
Proxy Filing1 Dec 2025 - Revenue fell but margins improved as global agent growth offset North America decline.RMAX
Q1 202523 Nov 2025 - Record agent count offset U.S. declines as revenue and EBITDA fell but margin improved.RMAX
Q2 202516 Nov 2025 - Q3 2025: Revenue down, margins up, record agent count, and innovation drive resilience.RMAX
Q3 20253 Nov 2025